A Leader in the Discovery and Development of Small Molecules that Disrupt Protein-Protein Interactions

Ascentage Pharma (6855.HK) founded in 2009, is a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and age-related diseases. The company aims to discovery and development of innovative first- and best-in-class therapies to address unmet medical needs globally. Learn More